Jonassen et al. AP1189, an oral melanocortin agonist in combination with MTX in early RA. Evidence of efficacy, no safety concerns. Looks promising! @RheumNow #ACR22 Abstr#1985 https://t.co/aK7BPwr5Ku https://t.co/9553KT2Pao
Links:
The BEGIN Study: A Double-blind, Multi-center, Two-part, Randomized, Placebo-co…
https://acrabstracts.org/abstract/the-begin-study-a-double-blind-multi-center-t…
14-11-2022